Norway - Biotech, Pharma and Life Science Channel
The Scandinavian country of Norway hosts a leading biotechnology industry. In 2009 a $418m stimulus package was established for the industry, to ensure it could continue to grow and ride out the financial crisis of the previous year.
In addition to this, $95 million was made available in loans to the industry by Innovation Norway, and $279 million was invested by Argentum. At the time, it was the most active political move in Europe to support the industry. Research in Norway is subsidized up to 50% by the Research Council of Norway.
The main aspect of the industry is the development of novel cancer therapies, with over 50 currently in the pipeline. Aside from the high quality research academic institutions, the following companies also operate in Norway; Amgen, AstraZeneca, Baxter, GE Healthcare, GSK, Nycomed, Pfizer and Sanofi-Aventis (all in the top 100 pharmaceutical companies in the world, based on annual sales.)
Source; Adapted from Norweign BioIndustry Association and FierceBioTech
Add the Norway News Channel to your RSS reader;
News Articles
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
Xellia is a leading developer and manufacturer of anti-infective therapies for multi-drug resistant infections. With this acquisition Novo expands its long-term investmen...
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
Xellia is a leading developer and manufacturer of anti-infective therapies for multi-drug resistant infections. With this acquisition Novo expands its long-term investment portfol...
MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 05/20/13 -- Epistem (LSE: EHP), the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological te...
Capio AB: Capio publishes Annual Review 2012
Capio, one of Sweden's and Europe's leading healthcare companies, publishes its Annual Review for 2012. Capio Annual Review 2012 presents Capio’s views and experiences...
Algeta ASA : Changes in Algeta's Financial Calendar 2013
Oslo, Norway, 15 May 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces changes to its financial calendar for 2013. New dates are...
Algeta schedules first quarter 2013 results presentation, webcast and conference call
Oslo, Norway, 7 May 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, will announce its first quarter 2013 results on Wednesday, 15 May 201...
Petroleum Geo-Services ASA : GeoStreamer Strengthens Profitability in an Improving Market
OSLO, NORWAY -- (Marketwired) -- 04/29/13 -- Highlights Q1 2013 · Revenues of $394.8 million, up 8% from Q1 2012 · EBITDA of $202.3 million, up 39% from Q1 2012 · EBIT of $96.8 mill...
SCA: SCA’s Divestments of Former Georgia-Pacific Units Approved
Regulatory News: In conjunction with SCA’s (STO:SCAA) (STO:SCAB) acquisition of Georgia-Pacific’s European tissue operations during the summer of 2012, the EU...
Algeta to Participate in Upcoming Investor Conference
Oslo, Norway, 17 April 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management and IR teams will...
Samsung Thales signs Development Agreement with Novelda
OSLO, Norway, April 15, 2013 /PRNewswire/ -- Samsung Thales, Co., Ltd (South Korea) has launched the development program of Vehicle-mounted Land Mine Detector. Samsung Thales' development will be...
Events
None
Companies
Mannatech develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. These p...
BerGenBio AS is an oncology-based biopharmaceutical company located in Bergen, Norway, focused on pursuing therapeutic treatments for cancer and supporting the screening and ident...
Digia, the software powerhouse listed in the NASDAQ OMX Helsinki exchange (DIG1V), is the worldwide exclusive commercial licensor of Qt. Digia has over 10 years of worldwide Qt ap...
Thin Film Electronics ASA (Ticker: THIN.OL) is a leader in the development of printed electronics. The first to commercialize printed rewritable memory, Thinfilm is creating print...
Verdande Technology AS was founded in 2004 and is headquartered in Trondheim, Norway, with regional offices in Houston, New York and Abu Dhabi, UAE. The company is privately funde...
Verdande Technology AS was founded in 2004 and is headquartered in Trondheim, Norway, with regional offices in New York, Houston and Abu Dhabi. The company is privately funded....
Lytix Biopharma AS develops novel drugs for treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments. The Company was established in 2...
Clinical Trials
Project:Intensive Habilitation (PIH)
The purpose of this study is to document that taking part in this program is beneficial for the child, its parents and local professionals. The study hypothesis are: Intensive trai...
Treatment for Cubital Tunnel Syndrome
The researchers want to find out the best treatment for cubital tunnel. The researchers establish the degree of nerve compression and then the patients are randomised to different treatmen...
Norwegian Study on District Treatment of ST-Elevation Myocardial Infarction
In the district areas of Norway patients with acute myocardial infarction with ST-elevation, are treated with thrombolysis. An increasing part of them receives thrombolysis before arrival...
Post-ERCP pancreatitis can be a serious complication to ERCP. Two studies have shown a promising preventive effect of glyceryl nitrate. This study should provide a final answer to the clin...
Postoperative wound disturbances, particularly surgical site infection of the chest and leg incision site following cardiac surgery are associated with increased morbidity, mortality, and...
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
An open clinical trial to study the immune response and safety after giving a booster dose (5th Dose) of a combination vaccine against Diphteria-Tetanus-Pertussis-Polio to healthy adolesce...
"How do Contrast Medias in Bone Cement Affect DXA Measurements After THR"
Joint replacement is a well-documented and cost effective treatment of degenerative diseases in the hip (1,2). There are two different principles of fixation of prosthesis components; ceme...
Prevention of Permanent Obesity in Children
In the county of Oppland, Norway, questionnaires addressing physical and mental health and socioeconomic status is issued to all (1960) families who meet for the pre-school assessment at t...
Meningococcal B Vaccination in University Students
This study is the third in a series using the MenB vaccine from the National Institute of Public Health in Norway (NIPH). The vaccine was first made in response to a high incidence of dise...
The Dementia Study in Northern Norway
The Dementia Study in Northern Norway is an open controled intervention trial carried out in nine rural municipalities, five of which allocated to intervention and four to control. A RCT w...
PubMed Articles
We have previously observed that 1-nitropyrene (1-NP) and its amine metabolite 1-aminopyrene (1-AP) induce differential chemokine responses in human bronchial epithelial cells (BEAS-2B) characterized...
Epigenetic regulation of the gene encoding steroidogenic factor-1.
The nuclear receptor steroidogenic factor 1 (SF-1) is expressed in a precise time and cell-specific pattern in the endocrine system. Three intronic enhancers and one upstream enhancer, which are requi...
Local adaptation within a hybrid species.
Ecological divergence among populations may be strongly influenced by their genetic background. For instance, genetic admixture through introgressive hybridization or hybrid speciation is likely to af...
A blood-feeding system that utilizes a small amount of whole heparinized human blood in parafilm bags is described in detail, and similarities and differences between artificially fed and naturally ro...
Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
South Korean isolates of oseltamivir-resistant influenza viruses from 2005-2010 were investigated with a total 491 influenza viruses identified from 1702 specimens. Neuraminidase genes from 342 influe...
Admission CTG: What are the consequences of the current evidence?
I thank Drs. Kessler and Yli for their comments where they ask if there is sufficient evidence to conclude anything about the admission CTG. There is sufficient evidence to state that the reliability...
Abducens palsy as a clue of unexpected contralateral cerebral sinovenous thrombosis.
Intracranial complications of acute and chronic otitis media can be difficult to recognize, as signs and symptoms are often subtle and variable across different age groups. In March, 2012, a 10-year-o...
Yes, we can - achieve adequate early postnatal growth in very preterm infants.
We compliment Christman and coworkers on their interesting work on early postnatal growth of preterm infants under different nutritional strategies. The authors concluded that "aggressive" enteral nut...
Can the Retinal Microvasculature offer Clues to Cardiovascular Risk Factors in Early Life?
Adulthood cardiovascular diseases (CVD) burdening in adulthood have been suggested to have possible predisposition early in life. We aimed to systematically review the literatures on retinal microvasc...
OBJECTIVE: To evaluate and compare the risk profile of sustaining obstetric anal sphincter injuries (OASIS) and associated risks in five risk groups (low to high), after the OASIS rate was reduced fro...
Videos
Margaret Berger - I Feed You My Love (Norway) - LIVE - 2013 Semi-Final (2)
Powered by http://www.eurovision.tv Norway: Margaret Berger - I Feed You My Love live at the Eurovision Song Contest 2013 Semi-Final (2)
Medical and Biotech [MESH] Definitions
Hebrides
A group of islands in the Atlantic Ocean west of Scotland, comprising the Outer Hebrides and the Inner Hebrides. They were the scene of frequent incursions of Scandinavian settlers from the 6th century A.D. They were ceded to Scotland by Norway in the 13th century. The origin of the name is uncertain. It is suggested that it is the result of a miscopying of the Roman name Ebudae or Hebudae with ri for u. (From Webster's New Geographical Dictionary, 1988, p496 & Room, Brewer's Dictionary of Names, 1992, p235)
